EU ingredient rules · 1 min read

Peg-90/polyepsilon Caprolactone in cosmetics: EU rules

Quick answer: Peg-90/polyepsilon Caprolactone is a restricted cosmetic ingredient in the EU: Annex III (entry 186) allows it only within set limits, at up to 0.1% in the ready-to-use product. CosIng lists its functions as emulsifier, humectant and cleansing surfactant.

Key facts

Peg-90/polyepsilon Caprolactone at a glance
INCI namePEG-90/POLYEPSILON CAPROLACTONE
EU statusRestricted (Annex III, entry 186)
Functions (CosIng)Emulsifier, Humectant, Cleansing surfactant

CosIng description: Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy- (90 mol EO average molar ratio), copolymer with poly-2-oxepanone

What it does in a product

  • Emulsifier: Lets oil and water blend into a cream or lotion.
  • Humectant: Attracts and holds water, which helps keep a product and skin moist.
  • Cleansing surfactant: Washes away dirt and oil.

Annex III: restricted substances, entry 186

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

The entry is listed as 2,2'-oxydiethanol Diethylene glycol (DEG)

Maximum concentration in the ready-to-use product: 0.1%

Product type or body part:

Most recent legal act listed by CosIng for this entry: Regulation (EC) 2013/344.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for PEG-90/POLYEPSILON CAPROLACTONE and Annex III/186, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.